302 related articles for article (PubMed ID: 33474589)
1. Neurological features and outcomes of Wilson's disease: a single-center experience.
Samanci B; Sahin E; Bilgic B; Tufekcioglu Z; Gurvit H; Emre M; Demir K; Hanagasi HA
Neurol Sci; 2021 Sep; 42(9):3829-3834. PubMed ID: 33474589
[TBL] [Abstract][Full Text] [Related]
2. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy.
Yuan XZ; Yang RM; Wang XP
Curr Neuropharmacol; 2021; 19(4):465-485. PubMed ID: 32351182
[TBL] [Abstract][Full Text] [Related]
3. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
[TBL] [Abstract][Full Text] [Related]
4. D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.
Członkowska A; Litwin T; Karliński M; Dziezyc K; Chabik G; Czerska M
Eur J Neurol; 2014 Apr; 21(4):599-606. PubMed ID: 24447648
[TBL] [Abstract][Full Text] [Related]
5. Restless legs syndrome in Wilson's disease: frequency, characteristics, and mimics.
Trindade MC; Bittencourt T; Lorenzi-Filho G; Alves RC; de Andrade DC; Fonoff ET; Bor-Seng-Shu E; Machado AA; Teixeira MJ; Barbosa ER; Tribl GG
Acta Neurol Scand; 2017 Feb; 135(2):211-218. PubMed ID: 26940540
[TBL] [Abstract][Full Text] [Related]
6. [A study of trientine therapy in Wilson's disease with neurological symptoms].
Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
[TBL] [Abstract][Full Text] [Related]
7. Tackling the neurological manifestations in Wilson's disease - currently available treatment options.
Litwin T; Dusek P; Antos A; Członkowska A; Bembenek J
Expert Rev Neurother; 2023; 23(12):1249-1259. PubMed ID: 37842984
[TBL] [Abstract][Full Text] [Related]
8. Early neurological deterioration in Wilson's disease: a systematic literature review and meta-analysis.
Antos A; Członkowska A; Smolinski L; Bembenek J; Przybyłkowski A; Skowrońska M; Kurkowska-Jastrzębska I; Litwin T
Neurol Sci; 2023 Oct; 44(10):3443-3455. PubMed ID: 37311952
[TBL] [Abstract][Full Text] [Related]
9. Early neurological worsening in patients with Wilson's disease.
Litwin T; Dzieżyc K; Karliński M; Chabik G; Czepiel W; Członkowska A
J Neurol Sci; 2015 Aug; 355(1-2):162-7. PubMed ID: 26071888
[TBL] [Abstract][Full Text] [Related]
10. Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson's disease.
Zhang J; Xiao L; Yang W
BMC Neurol; 2020 Jun; 20(1):255. PubMed ID: 32593295
[TBL] [Abstract][Full Text] [Related]
11. Childhood Wilson Disease: Bangladesh Perspective.
Rukunuzzaman M; Karim AB; Nurullah M; Sultana F; Mazumder MW; Rahman MA; Billah SB; Begum F; Oliullah M
Mymensingh Med J; 2017 Apr; 26(2):406-413. PubMed ID: 28588179
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and treatment of Wilson's disease: a single-centre experience.
Pellecchia MT; Criscuolo C; Longo K; Campanella G; Filla A; Barone P
Eur Neurol; 2003; 50(1):48-52. PubMed ID: 12824712
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Wilson's disease.
Subramanian I; Vanek ZF; Bronstein JM
Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
[TBL] [Abstract][Full Text] [Related]
14. Subclinical neurological involvement does not develop if Wilson's disease is treated early.
Dubbioso R; Ranucci G; Esposito M; Di Dato F; Topa A; Quarantelli M; Matarazzo M; Santoro L; Manganelli F; Iorio R
Parkinsonism Relat Disord; 2016 Mar; 24():15-9. PubMed ID: 26851839
[TBL] [Abstract][Full Text] [Related]
15. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
16. Wilson's disease: A master of disguise.
Hedera P
Parkinsonism Relat Disord; 2019 Feb; 59():140-145. PubMed ID: 30797706
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of patients with neurological form of Wilson's disease compliant to the de-coppering treatment.
Stanković I; Jovanović Č; Vitković J; Svetel M; Pekmezović T; Tomić A; Kresojević N; Marković V; Ječmenica Lukić M; Petrović I; Dragašević-Mišković N; Kostić V
J Neurol; 2023 Jul; 270(7):3492-3498. PubMed ID: 37016067
[TBL] [Abstract][Full Text] [Related]
18. Wilson's disease: a great masquerader.
Soltanzadeh A; Soltanzadeh P; Nafissi S; Ghorbani A; Sikaroodi H; Lotfi J
Eur Neurol; 2007; 57(2):80-5. PubMed ID: 17179709
[TBL] [Abstract][Full Text] [Related]
19. Recognition and treatment of neurologic Wilson's disease.
Lorincz MT
Semin Neurol; 2012 Nov; 32(5):538-43. PubMed ID: 23677665
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
